ZURZUVAE is a 14-day treatment
that may offer relief starting in 3 days
Rapid relief
starting at Day 3
See the results
starting at Day 3
In a clinical study, ZURZUVAE
improved PPD symptoms at
Day 15 and as fast as Day 3.
ZURZUVAE is taken
for 14 days
Get more details
for 14 days
Take it once daily in the
evening with fat-containing food.
Watch patient stories
Hear from others
Hear from women about their
experience with PPD and
ZURZUVAE.
*These are not all the symptoms of PPD. Only a healthcare provider can diagnose PPD.
ZURZUVAE 50 mg was studied in women with PPD whose symptoms started in the third trimester or within 4 weeks of delivery in a 6-week trial. During the trial, patients took either ZURZUVAE or placebo for 14 days, and were followed up for another 4 weeks. Significantly greater PPD symptom improvement was demonstrated at Day 3, Day 15 (the primary endpoint), and Day 45 compared to placebo, using a standard depression rating scale.
What is postpartum depression (PPD)?
PPD is a mood disorder that can affect women during pregnancy or anytime within the first 12 months after giving birth. It can cause extreme sadness, loss of interest in things, anxious mood, and fatigue that may make it hard to carry out daily tasks. These are not all the symptoms of PPD. Only a healthcare provider can diagnose PPD.
~1 in 8 women
report experiencing PPD
symptoms after giving birth.
What is ZURZUVAE?
ZURZUVAE is an oral treatment for women with PPD, taken once daily in the evening with fat-containing food for 14 days.
How is ZURZUVAE thought to work?
Hormonal changes during and after pregnancy can impact GABA, a chemical that helps balance mood, stress, and sleep among other things. Imbalances in GABA are one of the factors that may contribute to PPD. While the exact way ZURZUVAE works is not fully understood, it is believed to interact with the GABA system.
“I encourage women who are struggling with their symptoms to talk to their healthcare team. It can be really scary to ask for help, but there’s bravery and there’s courage in reaching out. There is hope out there.”
–Bethany, compensated patient treated with ZURZUVAE for PPD following the birth of her fourth child. Individual results may vary.
Talking to your healthcare provider about ZURZUVAE
Starting the conversation with your healthcare provider can help you both decide if ZURZUVAE is right for you. Here are some questions that can help guide the discussion.
Connecting through telehealth is also an option to find a healthcare provider.
Supernus Pharmaceuticals and Biogen are providing this link to an independent third party as a resource for your use. This link is not a
recommendation. Supernus Pharmaceuticals and Biogen are not responsible for nor do they control the content of any linked websites.
Getting started with ZURZUVAE
If you and your healthcare provider decide that ZURZUVAE is right for you, you’ll follow 3 steps to get started on treatment.
Find some answers to common questions about ZURZUVAE by visiting the FAQs page for helpful information on treatment, side effects, and support. You can also explore more resources and support tools on PPD for your ZURZUVAE treatment journey.
Cost info & support
ZURZUVAE For You is a patient support program available to help you as you navigate your journey with ZURZUVAE. The program includes patient support services and financial assistance* to help you access and manage your treatment.
*Financial assistance for eligible patients with commercial insurance under the ZURZUVAE Savings Card Program will be applied directly by the specialty pharmacy filling the prescription. Restrictions apply.
Please click for terms and conditions.